Adalimumab-Induced Isolated Peritoneal Tuberculosis
The therapeutic approach to immune-mediated diseases including Crohn’s disease has dramatically improved with the introduction of immunomodulators such as anti-tumor necrosis factor (TNF). However, its use is not complication-free, and since its introduction, a growing number of opportunistic infect...
Gespeichert in:
| Veröffentlicht in: | International journal of recent surgical and medical sciences 2023-04, Vol.10, p.S96-S100, Article S96 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The therapeutic approach to immune-mediated diseases including Crohn’s disease has dramatically improved with the introduction of immunomodulators such as anti-tumor necrosis factor (TNF). However, its use is not complication-free, and since its introduction, a growing number of opportunistic infections is being reported in patients under treatment despite all preventive measures taken. Herein, we report a case of adalimumab-induced isolated peritoneal tuberculosis. |
|---|---|
| ISSN: | 2455-7420 2455-0949 |
| DOI: | 10.1055/s-0043-1761477 |